簡介

本頁面提供了有關 Octavio Espinoza 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Octavio Espinoza已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:LGND / Ligand Pharmaceuticals Incorporated Chief Financial Officer 27,679
如何解讀這些圖表

以下圖表顯示了在Octavio Espinoza進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Octavio Espinoza 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-05-28 2026-05-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 972 27,679 3.64 52.84 51,360 1,462,558
2026-05-28 2026-05-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 764 26,707 2.94 63.62 48,606 1,699,099
2026-03-27 2026-03-02 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 4,933 37,945 14.94
2026-03-13 2026-03-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -3,057 21,010 -12.70 225.00 -687,825 4,727,250
2026-03-13 2026-03-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 2,405 24,067 11.10 92.65 222,823 2,229,808
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -3,413 21,662 -13.61 208.80 -712,621 4,522,939
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -2,457 25,075 -8.92 207.91 -510,823 5,213,223
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -1,588 27,532 -5.45 206.89 -328,542 5,696,106
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -1,457 29,120 -4.77 205.79 -299,841 5,992,713
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -743 30,577 -2.37 204.74 -152,125 6,260,485
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -668 31,320 -2.09 203.63 -136,024 6,377,651
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -697 31,988 -2.13 202.79 -141,343 6,486,760
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -950 32,685 -2.82 201.73 -191,640 6,593,434
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -698 33,635 -2.03 201.09 -140,364 6,763,793
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -53 34,333 -0.15 200.08 -10,604 6,869,268
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -699 34,386 -1.99 198.71 -138,895 6,832,677
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 466 35,085 1.35 80.72 37,616 2,832,061
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 1,607 34,619 4.87 58.49 93,993 2,024,865
2026-02-18 2026-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,270 33,012 -3.70 183.83 -233,464 6,068,596
2026-02-18 2026-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,223 34,282 -3.44 183.83 -224,824 6,302,060
2026-02-18 2026-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,026 35,505 -2.81 183.83 -188,610 6,526,884
2026-02-18 2026-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -4,483 36,531 -10.93 183.83 -824,110 6,715,494
2026-02-18 2026-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 8,810 41,014 27.36
2026-02-18 2026-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -3,761 32,204 -10.46 183.83 -691,385 5,920,061
2026-02-18 2026-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 7,390 35,965 25.86
2026-01-06 2025-12-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 8 28,575 0.03 95.68 765 2,733,942
2025-12-18 2025-12-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 181 28,567 0.64 103.42 18,719 2,954,399
2025-12-18 2025-12-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 652 28,386 2.35 92.65 60,408 2,629,963
2025-12-18 2025-12-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 285 27,734 1.04 63.62 18,132 1,764,437
2025-12-18 2025-12-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 69 27,449 0.25 57.22 3,948 1,570,632
2025-12-18 2025-12-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1,194 27,380 4.56 52.84 63,091 1,446,759
2025-12-16 2025-12-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -1,804 26,186 -6.45 188.31 -339,711 4,931,086
2025-12-09 2025-12-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,862 27,990 -6.24 184.87 -344,228 5,174,511
2025-07-02 3/A LGND LIGAND PHARMACEUTICALS INC
Common Stock
1,696
2025-07-02 2025-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 224 29,852 0.76 91.08 20,401 2,718,846
2025-05-13 2025-05-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 500 27,932 1.82 104.40 52,200 2,916,101
2025-05-13 2025-05-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1,000 27,432 3.78 103.89 103,890 2,849,910
2025-03-06 2025-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 7,484 26,363 39.64
2025-03-06 2025-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -5,000 18,879 -20.94 115.03 -575,148 2,171,646
2025-02-19 2025-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,221 23,879 -4.86 120.00 -146,520 2,865,480
2025-02-19 2025-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -782 25,100 -3.02 120.00 -93,840 3,012,000
2025-02-19 2025-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,024 25,882 -3.81 120.00 -122,880 3,105,840
2025-02-19 2025-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -3,803 26,906 -12.38 120.00 -456,360 3,228,720
2025-02-19 2025-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 7,390 30,709 31.69
2025-02-19 2025-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,757 23,319 -10.57 120.00 -330,840 2,798,280
2025-02-19 2025-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 5,429 26,076 26.29
2024-12-26 2024-12-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -2,104 20,647 -9.25 116.37 -244,850 2,402,770
2024-12-06 2024-12-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,859 22,751 -7.55 123.51 -229,605 2,809,976
2024-09-24 2024-09-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -800 24,610 -3.15 103.95 -83,160 2,558,210
2024-09-24 2024-09-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -275 25,410 -1.07 103.86 -28,562 2,639,146
2024-09-24 2024-09-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -200 25,685 -0.77 103.98 -20,796 2,670,726
2024-09-19 2024-09-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 69 25,885 0.27 57.22 3,948 1,481,140
2024-09-19 2024-09-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1,417 25,816 5.81 80.72 114,380 2,083,868
2024-08-30 2024-08-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 546 24,399 2.29 70.04 38,242 1,708,906
2024-08-30 2024-08-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 207 23,853 0.88 57.22 11,845 1,364,869
2024-07-02 2024-06-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 267 23,646 1.14 60.71 16,209 1,435,478
2024-05-17 2024-05-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -134 23,379 -0.57 86.65 -11,611 2,025,783
2024-05-17 2024-05-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -5,022 23,513 -17.60 86.67 -435,233 2,037,759
2024-05-17 2024-05-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 5,022 28,535 21.36 52.84 265,362 1,507,789
2024-05-17 2024-05-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 145 23,513 0.62 68.74 9,967 1,616,284
2024-05-17 2024-05-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1,544 23,368 7.07 63.62 98,229 1,486,672
2024-05-17 2024-05-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 206 21,824 0.95 57.22 11,787 1,248,769
2024-05-17 2024-05-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -2,264 21,618 -9.48 86.00 -194,712 1,859,222
2024-05-17 2024-05-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -5,873 23,882 -19.74 86.01 -505,148 2,054,139
2024-02-29 2024-02-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -140 29,755 -0.47 88.46 -12,384 2,632,127
2024-02-29 2024-02-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 325 29,895 1.10 58.49 19,009 1,748,559
2024-02-29 2024-02-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 140 29,570 0.48 57.22 8,011 1,691,995
2024-02-29 2024-02-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 799 29,430 2.79 55.75 44,544 1,640,722
2024-02-29 2024-02-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 7,208 28,631 33.65
2024-02-16 2024-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,479 21,423 -6.46 74.65 -110,407 1,599,227
2023-12-06 2023-12-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,269 22,902 -5.25 59.61 -75,645 1,365,188
2023-10-03 2023-10-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -346 24,171 -1.41 59.92 -20,732 1,448,326
2023-07-10 2023-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 375 24,517 1.55 56.78 21,292 1,392,075
2023-02-27 2023-02-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6,046 24,142 33.41
2023-02-17 2023-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -849 18,096 -4.48 72.98 -61,960 1,320,646
2023-01-04 2022-12-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 275 18,945 1.47 56.78 15,614 1,075,697
2022-12-15 2022-12-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 11,000 18,670 143.42
2022-12-01 2022-11-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,187 7,670 -13.40 72.90 -86,532 559,143
2022-11-10 2022-11-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -1,696 8,857 -16.07 75.64 -128,283 669,928
2022-11-07 3 LGND LIGAND PHARMACEUTICALS INC
Common Stock
10,553
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)